Bio-Rad Laboratories Class B
BIO.B
7 hedge funds and large institutions have $2.1M invested in Bio-Rad Laboratories Class B in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.
0.01% less ownership
Funds ownership: 0.12% → 0.11% (-0.01%)
24% less capital invested
Capital invested by funds: $2.75M → $2.1M (-$650K)
30% less funds holding
Funds holding: 10 → 7 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$46.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OPCM
Osborne Partners Capital Management
San Francisco,
California
|
-$206K |
| 2 |
PB
Pinnacle Bancorp
Beatrice,
Nebraska
|
-$1.39K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Renaissance Technologies
New York
| $705K | – | – | – |
|
|
CL
2
CSS LLC
Chicago,
Illinois
| $700K | – | – | – |
|
|
BSW
3
Buckingham Strategic Wealth
Clayton,
Missouri
| $286K | – | – | – |
|
4
Morgan Stanley
New York
| $272K | – | – | – |
|
|
5
Wells Fargo
San Francisco,
California
| $63.1K | +$46.1K | +114 | +204% |
|
|
WT
6
Whittier Trust
South Pasadena,
California
| $59.4K | – | – | – |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $18.8K | – | – | – |
|
|
OPCM
8
Osborne Partners Capital Management
San Francisco,
California
| – | -$206K | -434 | Closed |
|
|
PB
9
Pinnacle Bancorp
Beatrice,
Nebraska
| – | -$1.39K | -3 | Closed |
|
BIO.B Hedge Fund Activity: Q2 2023 in Review
7 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q2 2023, worth a combined $2.1M — down 24% from $2.75M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BIO.B and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Wells Fargo, adding an estimated $46.1K. The largest seller was Osborne Partners Capital Management, exiting entirely with an estimated $206K sold.
- 7 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q2 2023, down from 10 in Q1 2023.
- Funds reported $2.1M of Bio-Rad Laboratories Class B stock for Q2 2023, down 24% quarter-over-quarter.
- 0 funds opened new Bio-Rad Laboratories Class B positions in Q2 2023 and 3 closed out, a net change of -3 holders.
- The largest Bio-Rad Laboratories Class B buyer in Q2 2023 was Wells Fargo, an estimated $46.1K added.
- The largest Bio-Rad Laboratories Class B seller in Q2 2023 was Osborne Partners Capital Management, an estimated $206K sold.
Based on aggregated 13F filings for Q2 2023.